Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company  | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Moody's Corporation | Moody's | information technology | toxic securities abuses | 2017 | DOJ_CIVIL | $864,000,000 |
| Monsanto Company | Bayer | chemicals | PCB violation | 2022 | private lawsuit-federal | $537,500,000 |
| Monsanto Company | Bayer | chemicals | PCB violation | 2022 | OR-AG | $698,000,000 |
| Mobile TeleSystems PJSC | Mobile TeleSystems PJSC | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $750,000,000 |
| Mirror Trading International Proprietary Limited | investor protection violation | 2023 | CFTC | $1,700,000,000 | ||
| Mirant Corporation | NRG Energy | utilities and power generation | price-fixing or anti-competitive practices | 2005 | CA-AG | $749,700,000 |
| Microsoft Corporation | Microsoft | information technology | price-fixing or anti-competitive practices | 2006 | private lawsuit-state | $1,100,000,000 |
| MF Global Holdings Ltd. | investor protection violation | 2014 | CFTC | $1,312,000,000 | ||
| Merrill Lynch & Co. | Bank of America | financial services | investor protection violation | 2008 | MULTI-AG | $3,458,333,333 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| Merck & Company | Merck | pharmaceuticals | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
| Merck & Co., Inc. | Merck | pharmaceuticals | tax violations | 2007 | IRS | $2,300,000,000 |
| Merck & Co. | Merck | pharmaceuticals | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $4,850,000,000 |
| MERCEDES-BENZ USA, LLC | Mercedes-Benz Group | motor vehicles | air pollution violation | 2021 | EPA | $875,000,000 |
| Mercedes-Benz USA LLC | Mercedes-Benz Group | motor vehicles | air pollution violation | 2021 | private lawsuit-federal | $700,000,000 |
| McKinsey & Company | McKinsey | business services | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $573,000,000 |
| McKesson Corporation | McKesson | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $8,001,000,000 |
| Mastercard International Inc. | MasterCard | financial services | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $2,100,000,000 |
| Mastercard International Inc. | MasterCard | financial services | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $1,025,000,000 |
| Marsh & McLennan Companies, Inc. | Marsh & McLennan | financial services | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $850,000,000 |
| Mallinckrodt | Mallinckrodt | pharmaceuticals | Controlled Substances Act violation | 2020 | MULTI-AG | $1,600,000,000 |
| Libre by Nexus, Inc. | consumer protection violation | 2024 | MULTI-AG | $811,000,000 | ||
| Lexington Law and CreditRepair.com | consumer protection violation | 2023 | CFPB | $2,700,000,000 | ||
| Lafarge S.A. | Holcim Group | building materials | payment to designated terrorist organization | 2022 | USAO | $777,780,000 |
| Kroger | Kroger | retailing | off-label or unapproved promotion of medical products | 2023 | MULTI-AG | $1,370,000,000 |
| Knauf Plasterboard Tianjin | Knauf | building materials | product safety violation | 2013 | private lawsuit-federal | $1,000,000,000 |
| JPMorgan Chase Bank | JPMorgan Chase | financial services | anti-money-laundering deficiencies | 2014 | USAO | $1,700,000,000 |
| JPMorgan Chase & Company | JPMorgan Chase | financial services | investor protection violation | 2020 | CFTC | $920,200,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | mortgage abuses | 2012 | DOJ | $5,333,600,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $550,000,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | fraud | 2020 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $920,000,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | consumer protection violation | 2015 | private lawsuit-federal | $505,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | banking violation | 2013 | OCC | $1,958,450,341 |
| JPMorgan Chase | JPMorgan Chase | financial services | False Claims Act and related | 2014 | DOJ_CIVIL | $614,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | DOJ | $13,000,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,121,188,661 |
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,066,000,000 |
| JP Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2008 | MULTI-AG | $3,525,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $5,000,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
| Invista | Koch Industries | diversified | environmental violation | 2009 | EPA | $501,700,000 |
| ING Bank N.V. | ING | financial services | economic sanction violation | 2012 | DOJ_CRIMINAL | $619,000,000 |
| ING Bank N.V. | ING | financial services | economic sanction violation | 2012 | OFAC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $619,000,000 |
| Indivior Solutions | Indivior PLC | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
| Hyundai Motor America | Hyundai Motor | motor vehicles | product safety violation | 2021 | private lawsuit-federal | $1,300,000,000 |
| HSBC North America Holdings Inc. | HSBC | financial services | toxic securities abuses | 2014 | FHFA | $550,000,000 |
| HSBC Holdings plc HSBC Bank USA N.A. | HSBC | financial services | anti-money-laundering deficiencies | 2012 | DOJ_CRIMINAL | $1,256,000,000 |
| HSBC | HSBC | financial services | toxic securities abuses | 2018 | USAO | $765,000,000 |
| HOVENSA LLC | air pollution violation | 2011 | EPA | $705,375,000 | ||
| HCA-The Healthcare Company | HCA Healthcare | healthcare services | False Claims Act and related | 2000 | DOJ_CIVIL | $840,000,000 |
| HCA Inc. | HCA Healthcare | healthcare services | False Claims Act and related | 2003 | DOJ_CIVIL | $631,000,000 |
| Halliburton Energy Services Inc. | Halliburton | oilfield services and supplies | oil spill | 2017 | private lawsuit-federal | $1,028,000,000 |
| Gunvor S.A. | Foreign Corrupt Practices Act | 2024 | DOJ_CRIMINAL | $661,698,515 | ||
| GTV Media Group Inc., Saraca Media Group Inc., and Voice of Guo Media Inc. | investor protection violation | 2021 | SEC | $539,000,000 | ||
| Google LLC | Alphabet Inc. | information technology | consumer protection violation | 2023 | MULTI-AG | $700,000,000 |
| Goldman Sachs Group, Inc. | Goldman Sachs | financial services | investor protection violation | 2008 | MULTI-AG | $3,355,833,333 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $2,921,088,000 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | SEC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,006,000,000 |
| Goldman Sachs & Co. | Goldman Sachs | financial services | toxic securities abuses | 2010 | SEC | $550,000,000 |
| Goldman Sachs & Co. | Goldman Sachs | financial services | toxic securities abuses | 2014 | FHFA | $3,150,000,000 |
| Goldman Sachs | Goldman Sachs | financial services | toxic securities abuses | 2016 | DOJ | $5,060,000,000 |
| Glencore International A.G. and Glencore Ltd. | Glencore | financial services | Foreign Corrupt Practices Act | 2022 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,185,000,000 |
| Glencore International A.G. | Glencore | financial services | price-fixing or anti-competitive practices | 2022 | CFTC | $1,186,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
| General Motors | General Motors | motor vehicles | motor vehicle safety violation | 2015 | NHTSA | $900,000,000 |
| General Electric | General Electric | diversified | toxic securities abuses | 2019 | DOJ_CIVIL | $1,500,000,000 |
| Fox Corp. | Fox Corporation | media | defamation | 2023 | private lawsuit-state | $787,500,000 |
| Forest Laboratories LLC | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $750,000,000 |
| Fiat Chrysler Automobiles N.V. | Stellantis | motor vehicles | air pollution violation | 2019 | EPA | $515,000,000 |
| Facebook, Inc. | Meta Platforms Inc. | information technology | privacy violation | 2019 | FTC | $5,000,000,000 |
| Meta Platforms Inc. | information technology | privacy violation | 2021 | private lawsuit-federal | $650,000,000 | |
| ExxonMobil | Exxon Mobil | oil and gas | air pollution violation | 2005 | EPA | $589,400,000 |
| Exxon Corporation | Exxon Mobil | oil and gas | environmental violation | 2008 | private lawsuit-federal | $507,500,000 |
| Exxon Corporation | Exxon Mobil | oil and gas | price-fixing or anti-competitive practices | 2006 | private lawsuit-federal | $1,075,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $520,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | SEC | $539,000,000 |
| Equifax | Equifax | miscellaneous services | consumer protection violation | 2019 | CFPB | $525,000,000 |
| Epic Games, Inc. | Epic Games Inc. | entertainment | privacy violation | 2022 | FTC | $520,000,000 |
| Enron | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $1,520,000,000 | ||
| Endo International PLC | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2017 | private lawsuit-federal | $775,000,000 |
| Endo International PLC | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $830,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | drug or medical equipment safety violation | 2005 | private lawsuit-federal | $690,000,000 |
| El Paso Corporation | Kinder Morgan | pipelines | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $1,450,000,000 |
| East Kentucky Power Cooperative | East Kentucky Power Cooperative | utilities and power generation | air pollution violation | 2007 | EPA | $650,750,000 |
| Dynegy Midwest Generation | Vistra Energy | utilities and power generation | air pollution violation | 2005 | EPA | $524,000,000 |
| Duke Energy | Duke Energy | utilities and power generation | environmental violation | 2021 | NC-AG | $855,000,000 |
| Dow Chemical | Dow Inc. | chemicals | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $835,000,000 |
| Deutsche Bank Securities, Inc. and Deutsche Bank AG | Deutsche Bank | financial services | investor protection violation | 2008 | MULTI-AG | $3,348,333,333 |
| Deutsche Bank AG | Deutsche Bank | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $775,000,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | toxic securities abuses | 2013 | FHFA | $1,925,000,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | tax violations | 2010 | USAO | $553,633,153 |
| Deutsche Bank | Deutsche Bank | financial services | price-fixing or anti-competitive practices | 2015 | CFTC | $800,000,000 |
| Deutsche Bank | Deutsche Bank | financial services | toxic securities abuses | 2017 | DOJ_CIVIL | $7,200,000,000 |
| Deutsche Bank | Deutsche Bank | financial services | price-fixing or anti-competitive practices | 2015 | NY-DFS | $600,000,000 |
| DePuy Orthopaedics, Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
